BioLife Solutions ROE 2006-2019 | BLFS

Current and historical return on equity (ROE) values for BioLife Solutions (BLFS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. BioLife Solutions ROE for the three months ending March 31, 2019 was 10.32%.
BioLife Solutions ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.00B $0.04B 7.95%
2018-12-31 $0.00B $0.04B 10.26%
2018-09-30 $0.00B $0.04B 4.76%
2018-06-30 $0.00B $0.02B 0.00%
2018-03-31 $-0.00B $0.01B -23.53%
2017-12-31 $-0.00B $0.01B -44.44%
2017-09-30 $-0.01B $0.01B -100.00%
2017-06-30 $-0.01B $0.01B -120.00%
2017-03-31 $-0.01B $0.00B -114.29%
2016-12-31 $-0.01B $0.00B -88.89%
2016-09-30 $-0.00B $0.01B -47.06%
2016-06-30 $-0.00B $0.01B -42.11%
2016-03-31 $-0.00B $0.01B -38.10%
2015-12-31 $-0.00B $0.01B -34.78%
2015-09-30 $-0.00B $0.01B -32.00%
2015-06-30 $-0.00B $0.01B -30.77%
2015-03-31 $-0.00B $0.01B -30.19%
2014-12-31 $-0.00B $0.01B -29.63%
2014-09-30 $-0.00B $0.01B -44.44%
2014-06-30 $-0.00B $0.01B -800.00%
2014-03-31 $-0.00B $0.01B 16.00%
2013-12-31 $0.00B $-0.01B 0.00%
2013-09-30 $-0.00B $-0.01B 8.00%
2013-06-30 $-0.00B $-0.01B 8.16%
2013-03-31 $-0.00B $-0.01B 8.33%
2012-12-31 $-0.00B $-0.01B 8.51%
2012-09-30 $0.00B $-0.01B 0.00%
2012-06-30 $0.00B $-0.01B 0.00%
2012-03-31 $0.00B $-0.01B 0.00%
2011-12-31 $-0.00B $-0.01B 9.52%
2011-09-30 $-0.00B $-0.01B 9.76%
2011-06-30 $-0.00B $-0.01B 10.26%
2011-03-31 $-0.00B $-0.01B 21.05%
2010-12-31 $-0.00B $-0.01B 22.22%
2010-09-30 $-0.00B $-0.01B 23.53%
2010-06-30 $-0.00B $-0.01B 37.50%
2010-03-31 $-0.00B $-0.01B 40.00%
2009-12-31 $-0.00B $-0.01B 42.86%
2009-09-30 $-0.00B $-0.01B 64.00%
2009-06-30 $-0.00B $-0.01B 72.73%
2009-03-31 $-0.00B $-0.01B 84.21%
2008-12-31 $-0.00B $-0.01B 100.00%
2008-09-30 $-0.00B $-0.00B 123.08%
2008-06-30 $-0.00B $-0.00B 145.45%
2008-03-31 $-0.00B $-0.00B 200.00%
2007-12-31 $-0.00B $-0.00B 320.00%
2007-09-30 $-0.00B $-0.00B 400.00%
2007-06-30 $-0.00B $-0.00B 800.00%
2007-03-31 $-0.00B $0.00B -400.00%
2006-12-31 $0.00B $0.00B 0.00%
2006-09-30 $0.00B $0.00B 0.00%
2006-06-30 $0.00B $0.00B 0.00%
2006-03-31 $0.00B $0.00B nan%
2005-12-31 $0.00B $0.00B nan%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.319B $0.020B
BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00